Skip to main content

Day: June 23, 2021

WillScot Mobile Mini Announces Pricing of Secondary Offering

PHOENIX, June 23, 2021 (GLOBE NEWSWIRE) — WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini” or the “Company”) (Nasdaq: WSC), a North American leader in modular space and portable storage solutions, today announced the pricing of its previously announced underwritten, secondary offering (the “Offering”) of 14,000,000 shares (the “Shares”) of its common stock, par value $0.0001 per share (the “Common Stock”). The Shares have been offered by the Company’s principal shareholder, Sapphire Holding S.à r.l., an entity controlled by TDR Capital (the “Selling Stockholder”), at a price to the public of $27.95 per share. The Selling Stockholder granted the underwriter a 30-day option to purchase up to an additional 2,100,000 shares. The Company has not offered any shares in the Offering and will not receive any of the proceeds from...

Continue reading

Green Hydrogen Generator Market to Exhibit a CAGR of 5.6% by 2028; Acquisition of Areva H2Gen by GTT to Amplify Growth: Fortune Business Insights™

List of the Companies Profiled in the Market: Asahi Kasei, Hydrogenics, Areva H2gen,Shandong Saikesaisi Hydrogen Energy Co., Ltd., Teledyne Energy Systems, Siemens AG, Kobelco Eco-Solutions, McPhy, Yangzhou Chungdean Hydrogen Equipment Co., Ltd, Suzhou Jingli, TianJin Mainland, ITM Power, 718th Research Institute of CSIC, Idroenergy Spa, Erredue SpA, MVS Engineering, GreenHydrogen.dk, Enapter, Giner Inc, ShaanXi HuaQin, Next Hydrogen, H-Tec Systems GmbH, Beijing Zhondian Pune India, June 23, 2021 (GLOBE NEWSWIRE) — The global green hydrogen generator market size is expected to reach USD 325.1 million by 2028, exhibiting a CAGR of 5.6% between 2021 and 2028. The surging demand for fuel cell-based electric vehicles and buses will propel healthy growth of the market, states Fortune Business Insights, in a report, titled “Green Hydrogen...

Continue reading

SCYNEXIS to Present Commercial Launch Update for BREXAFEMME® (ibrexafungerp tablets)

BREXAFEMME® (ibrexafungerp tablets), for oral useA novel oral antifungal approved for the treatment of vulvovaginal candidiasis (VVC), also known as vaginal yeast infectionBREXAFEMME, a one-day, novel, oral treatment for vaginal yeast infection, is the first FDA-approved indication of the ibrexafungerp antifungal development pipeline and the first approved drug from a novel antifungal class in over 20 years Commercial launch update call is scheduled for Tuesday, June 29th @ 12pm ETJERSEY CITY, N.J., June 23, 2021 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant fungal infections, today announced that it will present a commercial launch update for its recently FDA-approved drug, BREXAFEMME® (ibrexafungerp...

Continue reading

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Learns from First Movers in Cannabis Space

NEW YORK, June 23, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication, “A Lesson in Cannabis: Second Mover Can Be Better Position,” please visit: https://nnw.fm/VJcx0. Even though medical marijuana had been legal in some U.S. states for more than a decade, the substance didn’t gain much recognition until Colorado set the market on its head in 2012 by making adult-use marijuana legal. Since then, other states have followed suit, while in 2018, Canada went all-in to become the first developed nation with...

Continue reading

XBiotech Announces First Patient Enrolled in Clinical Trial Evaluating XB2001 for the Treatment of Pancreatic Cancer

XB2001 Is a Novel Therapy that Interrupts Inflammation to Potentially Block Growth and Spread of Tumors and to Reduce Toxicity of Chemotherapy Treatment AUSTIN, Texas, June 23, 2021 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) has enrolled the first patient in its 1-BETTER study, a randomized, double-blind, placebo-controlled clinical study to evaluate XB2001 in combination chemotherapy for treatment of Pancreatic Cancer. XBiotech’s novel anti-cancer agent, XB2001, is being assessed in combination with ONIVYDE + 5-FU/LV chemotherapy regimens. Safety and tolerability of the regimen, as well as progression-free survival, overall survival and time-to-treatment-failure will be assessed in the study. XB2001 blocks inflammation pathways turned on by tumors that help tumors vascularize, spread and cause collateral damage to healthy...

Continue reading

Uranium Energy Corp. (NYSE American: UEC) Leads Out in ISR Uranium Mining

NEW YORK, June 23, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Uranium Energy Corp. (NYSE American: UEC) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication, “Time to Capitalize on the Net Zero Emission Initiative,” please visit: https://nnw.fm/jtRjZ. Last month, the International Energy Agency (IEA) issued a comprehensive and actionable plan to cap the global temperature rise to 1.5°C by mid-century without upending energy stability, accessibility or pricing. IEA covers it all and lays out how renewable energies in combination with nuclear power will become the dominant energy sources across the planet even...

Continue reading

Betsy Schaefer joins FuelCell Energy as Chief Marketing Officer

DANBURY, Conn., June 23, 2021 (GLOBE NEWSWIRE) — FuelCell Energy, Inc. (Nasdaq: FCEL) — a global leader in fuel cell technology with a purpose of utilizing its proprietary, state-of-the-art fuel cell platforms to enable a world empowered by clean energy— today announced that Betsy Schaefer joined its team as the new Chief Marketing Officer. Betsy brings a wealth of experience to FuelCell Energy having built a decorated career at IBM in corporate communications, marketing and brand management where she most recently led marketing for the Watson AI division. Betsy is an innovative and technology-focused marketing professional with extensive experience in crafting brand strategies, managing high performance teams and driving marketing initiatives. Her experience as a leader in product, performance content marketing, with expertise...

Continue reading

PSYC Interviews CA Senator Scott Wiener to Discuss Efforts to Legalize Psychedelics

PSYC Examines Senate Bill 519 Which Aims to Decriminalize Psychedelics in California LAKE OSWEGO,OR, June 23, 2021 (GLOBE NEWSWIRE) — Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) a leading publicly traded digital media company within the emerging sector of medicinal psychedelics, is pleased to announce that the Company’s CEO, David Flores, recently sat down with CA Senator Scott Wiener (D-San Francisco) as part of an exclusive Psychedelic Spotlight interview to discuss Senate Bill 519 which aims to decriminalize the possession and sharing of certain hallucinogenic/psychedelic substances within the state. The measure, which was introduced by Senator Wiener earlier this year, cleared its first major hurdle this month when it was passed in a 21-16 vote by the state Senate resulting in it moving on...

Continue reading

Imperial Mining Receives Final Crater Lake Drill Results: Data Sent to Engineers for 43-101 Resource Estimation on TG Zone

Figure 1Crater Lake Drillhole Location MapFigure 2Diamond Drill Cross-Section 400N, TG Zone, Crater Lake Project, QuebecFigure 3Diamond Drill Cross-Section 600N, TG Zone, Crater Lake Project, QuebecHighlights:Assay results from the first four drillholes continue to return impressive intercepts of 99.8 m (327.3’) grading 299 g/t scandium oxide (Sc2O3), including 24.2 m (79.4’) grading 331 g/t Sc2O3 and 77.3 m (253.5′) grading 313 g/t Sc2O3. Elevated levels of total rare earth oxides plus yttrium (TREO+Y) of up to 0.46 % characterize the scandium-bearing intercepts.All drill assays have been received and the data has been transferred to our engineering group to complete the 43-101 resource estimation work on the TG Zone.MONTREAL, June 23, 2021 (GLOBE NEWSWIRE) — Imperial...

Continue reading

James River Announces Retirement of President & COO

PEMBROKE, Bermuda, June 23, 2021 (GLOBE NEWSWIRE) — James River Group Holdings, Ltd. (“James River” or the “Company”) (NASDAQ: JRVR) today announced the retirement of Robert P. (Bob) Myron, President and Chief Operating Officer, after more than 11 years with the organization. Mr. Myron will retire effective July 31, 2021 for health reasons related to lingering effects of Lyme Disease. The Company and Mr. Myron expect to maintain a consulting relationship through December 31, 2021. Frank D’Orazio, the Company’s Chief Executive Officer, commented, “I’d like to thank Bob for his numerous contributions to the Company. He has led operations at every level of the Company, including as CEO and as a member of the Board of Directors. Throughout his distinguished tenure at James River, Bob has demonstrated outstanding leadership and dedication...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.